Fleishman J - Search Results

1

Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management.

Dewanjee S, Bhattacharya H, Bhattacharyya C, Chakraborty P, Fleishman J, Alexiou A, Papadakis M, Jha SK. Dewanjee S, et al. Among authors: fleishman j. Cell Commun Signal. 2024 Oct 15;22(1):497. doi: 10.1186/s12964-024-01878-2. Cell Commun Signal. 2024. PMID: 39407193 Free PMC article. Review.

2

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.

Fleishman JS, Kumar S. Fleishman JS, et al. Signal Transduct Target Ther. 2024 Apr 26;9(1):97. doi: 10.1038/s41392-024-01811-6. Signal Transduct Target Ther. 2024. PMID: 38664391 Free PMC article. Review.

3

Research progress on gene mutations and drug resistance in leukemia.

Ma X, Xu J, Wang Y, Fleishman JS, Bing H, Yu B, Li Y, Bo L, Zhang S, Chen ZS, Zhao L. Ma X, et al. Among authors: fleishman js. Drug Resist Updat. 2024 Dec 26;79:101195. doi: 10.1016/j.drup.2024.101195. Online ahead of print. Drug Resist Updat. 2024. PMID: 39740374 Review.

4

Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review).

Wang Y, Fleishman JS, Li Y, Cao Y, Wei H, Zhang Z, Chen J, Ding M. Wang Y, et al. Among authors: fleishman js. Int J Oncol. 2025 Jan;66(1):8. doi: 10.3892/ijo.2024.5714. Epub 2024 Dec 13. Int J Oncol. 2025. PMID: 39670309 Free PMC article. Review.

5

Targeting novel regulated cell death：Ferroptosis, pyroptosis, and autophagy in sepsis-associated encephalopathy.

Sun J, Fleishman JS, Liu X, Wang H, Huo L. Sun J, et al. Among authors: fleishman js. Biomed Pharmacother. 2024 May;174:116453. doi: 10.1016/j.biopha.2024.116453. Epub 2024 Mar 20. Biomed Pharmacother. 2024. PMID: 38513593 Free article. Review.

6

Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics.

Khairnar R, Islam MA, Fleishman J, Kumar S. Khairnar R, et al. Among authors: fleishman j. Life Sci. 2023 Jan 1;312:121185. doi: 10.1016/j.lfs.2022.121185. Epub 2022 Nov 12. Life Sci. 2023. PMID: 36375569 Review.

7

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases.

Wang Y, Hu J, Wu S, Fleishman JS, Li Y, Xu Y, Zou W, Wang J, Feng Y, Chen J, Wang H. Wang Y, et al. Among authors: fleishman js. Signal Transduct Target Ther. 2023 Dec 10;8(1):449. doi: 10.1038/s41392-023-01720-0. Signal Transduct Target Ther. 2023. PMID: 38072908 Free PMC article. Review.

8

Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance.

Wang H, Fleishman JS, Cheng S, Wang W, Wu F, Wang Y, Wang Y. Wang H, et al. Among authors: fleishman js. Mol Cancer. 2024 Aug 27;23(1):177. doi: 10.1186/s12943-024-02088-7. Mol Cancer. 2024. PMID: 39192329 Free PMC article. Review.

9

The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond.

Chen DQ, Xie Y, Cao LQ, Fleishman JS, Chen Y, Wu T, Yang DH. Chen DQ, et al. Drug Resist Updat. 2024 Mar;73:101062. doi: 10.1016/j.drup.2024.101062. Epub 2024 Jan 29. Drug Resist Updat. 2024. PMID: 38330827 Review.

10

Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies.

Cao LQ, Xie Y, Fleishman JS, Liu X, Chen ZS. Cao LQ, et al. Among authors: fleishman js. Cancer Lett. 2024 Aug 10;597:217061. doi: 10.1016/j.canlet.2024.217061. Epub 2024 Jun 13. Cancer Lett. 2024. PMID: 38876384 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters